Arpit Batish

This paper demonstrates an automated, high-throughput platform for manufacturing gene-edited hematopoietic stem and progenitor cells (geHSPCs) with preserved function and in vivo engraftment capacity.

This paper develops a robotic system to automate cell therapy manufacturing, demonstrating comparable results to manual methods in expanding human CD8+ T cells.